EULAV Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
EULAV Asset Management's LLY Position: Q3 2026 in Review
EULAV Asset Management reduced its Eli Lilly (LLY) stake by 1.1% in Q3 2026, selling an estimated $118K and leaving 8,910 shares worth $10.3M. The position accounts for 0.37% of the portfolio, ranked #79.
EULAV Asset Management first reported a position in LLY in Q2 2013 and has held it in 10 quarters since. The position peaked at $10.8M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- EULAV Asset Management held 8,910 shares of Eli Lilly worth $10.3M as of Q3 2026.
- EULAV Asset Management sold 100 Eli Lilly shares in Q3 2026, an estimated $118K.
- Eli Lilly made up 0.37% of EULAV Asset Management's portfolio in Q3 2026, its #79 holding.
- EULAV Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 10 quarters since.
- EULAV Asset Management's Eli Lilly position peaked at $10.8M in Q2 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on EULAV Asset Management's 13F filing for Q3 2026, filed 23 Oct 2026.